Agoracom Blog Home

Posts Tagged ‘#smallcapstocks’

Pilley’s Island Trench Samples Return up to 27.5% Zinc, 20.0% Lead, 8.36% Copper and 63.4 g/t Silver, Newfoundland $AGB.ca $MOZ.ca $SZM.ca

Posted by AGORACOM at 10:09 AM on Thursday, November 16th, 2017

  • Pilley’s Island Base Metal – Precious Metal Property- Located in North-Central Newfoundland
  • Grab samples collected from trenches returned up to 27.5% Zn, 20.0% Pb, 8.36% Cu and 63.4 g/t Ag
  • Diamond drill program is to commence in late November.

 

Vancouver, British Columbia (FSCwire)GREAT ATLANTIC RESOURCES CORP. (TSXV.GR) (the “Company” or “Great Atlantic”) is pleased to announce it has received initial analytical results for rock samples collected during a recent trenching program at its Pilley’s Island Base Metal – Precious Metal Property, located in north-central Newfoundland. The exploration program was jointly operated with option partner Unity Resources. Rock grab samples collected from the trenches returned up to 27.5% Zn, 20.0% Pb, 8.36% Cu and 63.4 g/t Ag. Great Atlantic and Unity Resources are planning a diamond drilling program on the property to commence in late November. The property hosts an historic copper mine along with several zinc, lead, copper (+ / – gold, silver) occurrences.

 

 

One area of recent trenching was the Bull Road showing. Previous historic work included trenching and drilling with 7 holes sunk on the showing. Reported historic trench samples at Bull Road include 12.42% Zn, 3.87% Cu, 0.95% Pb and 0.71 oz./ton Ag over 4.6m. One historic drill hole at this showing was reported to intersect 22.2% Zn, 4.4% Pb, 0.1% Cu and 0.96 oz./ton Ag over 0.65m core length within an intersection of 7.85m grading 0.66% Cu, 0.51% Pb, 3.41% Zn and 0.34 oz./ton Ag. The recent trenching program included re-opening and re-evaluating the historic Bull Road Showing.

 

Trenching along the trace of the Bull Road Showing exposed mineralization over a length of 130m with a width varying between 1-7m. The Bull Road Showing is a polylithic slump breccia of volcanogenic massive sulphide mineralization containing massive sulphide clasts up to greater than a metre in length.

 

Rock grab samples taken from selected styles of mineralization during the current program are presented in the table below.

 

Massive sulfide mineralization at Bull Road Trench.

To view the graphic in its original size, please click here

 

Massive sulfide mineralization at Bull Road Trench

To view the graphic in its original size, please click here

 

Massive sulfide mineralization at Bull Road Trench

To view the graphic in its original size, please click here

 

Bull Road Trench

To view the graphic in its original size, please click here

 

The Bull Road showing will be targeted during the upcoming diamond drill program.

 

The Pilley’s Island Property hosts an historic mine with reported historic estimated reserves of 1.159 million tonnes grading 1.23% Cu or 627,373 tons at 2.34% Cu and 0.01 oz./ton Au. This volcanogenic massive sulphide deposit is analogous to Kuroko/Buchans style mineralization. The Property also hosts other base metal – precious metals occurrences including the Bull Road showing and Fragmental Zone.

 

The Pilley’s Island Property consists of 7 adjoining licences covering a total are of 875 hectares. Access to and infrastructure at the property is excellent. The property is serviced with power mains and government maintained roads and is within 2 km of tide water. The property is located within a mining friendly district.

PyroGenesis $PYR.ca Announces $1.02 Million Sale of 2nd DROSRITE™ Furnace System to North American Automobile Parts Manufacturer $TSLA $DDD $SSYS $PRLB

Posted by AGORACOM-JC at 8:42 AM on Thursday, November 16th, 2017

Pyr header 1

  • Announced today that it has received a purchase order, in the amount of US$ 800,000 (Can$ 1.02 million), for the sale of a second DROSRITE™ Furnace System
  • Purchaser is a North American automobile parts manufacturer

MONTREAL, Nov. 16, 2017 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V:PYR) (OTCQB:PYRNF), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma waste-to-energy systems and plasma torch products, announces today that it has received a purchase order, in the amount of US$ 800,000 (Can$ 1.02 million), for the sale of a second (2nd) DROSRITE™ Furnace System (the “System”) to a North American automobile parts manufacturer (the “Client”).

The system is the second (2nd) commercial System sold to date and represents a re-order from the Client; the name of which remains confidential for competitive reasons. Delivery is scheduled to be in Q2-2018, and the contract calls for a fifty percent (50%) down payment and ten percent (10%) holdback.

PyroGenesis’ DROSRITE™ System is a salt-free, cost-effective, sustainable process for maximizing metal recovery from dross, a waste generated in the metallurgical industry. PyroGenesis’ patented process avoids costly loss of metal while reducing a smelter’s carbon footprint and energy consumption, providing an impressive return on investment.

“With aluminum manufacturers being subjected to increased pressure from regulatory authorities, requiring them to eliminate landfilling of hazardous salt cakes from traditional recovery operations, combined with tight operating margins, PyroGenesis’ DROSRITE™ System is able to (i) increase metal recovery from waste, without producing any hazardous by-products, while (ii) reducing operating costs,” said Mr. Pierre Carabin, Chief Technology Officer of PyroGenesis.

Additionally, as previously announced, PyroGenesis had received an unsolicited offer from a waste management company to be the sole distributor of PyroGenesis’ DROSRITE™ System within the Gulf Cooperation Council (the “GCC”). A successful DROSRITE™ demonstration was conducted at a major aluminum smelter, following which a formal visit took place at PyroGenesis’ facility in Montreal, Canada. Negotiations for the sale of DROSRITE™ Systems are currently underway.

Separately, a potential client from India has engaged PyroGenesis to perform a pilot demonstration at its manufacturer facility. The pilot system is currently being deployed to India for a demonstration scheduled in Q1-2018.

“PyroGenesis has recently hired a dedicated business development professional to address the growing demand for DROSRITE™,” said Massimo Dattilo, VP, Business Development of PyroGenesis. “Given our existing Client’s need for an additional 2 systems; combined with the continuing demand from the Middle East; and the fact that the Company’s demonstration unit is currently in-transit to India, all reflects, we believe, DROSRITE™â€™s success at addressing a serious need within the aluminum industry. The Company is currently targeting primary aluminum smelters in Asia and the Middle East where the market is estimated to be in excess of 1 million tonnes of dross1, as well as tertiary casting producers worldwide, all of which we expect will represent a potential requirement for DROSRITE™ systems numbering in the hundreds of units.”

“We expect DROSRITE™ to be a significant contributor to the operations of our non-additive business segments,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis. “It underscores the success of our strategic plan in targeting high value niche problems in various industries. The fact that we have one of the largest concentrations of plasma expertise, under one roof, gives us the unique advantage of being able to target, and address, these opportunities.”

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc. is the world leader in the design, development, manufacture and commercialization of advanced plasma processes. PyroGenesis provides engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Its core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Its operations are ISO 9001:2008 certified, and have been ISO certified since 1997. PyroGenesis is a publicly-traded Canadian company on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace (Ticker Symbol: PYRNF). For more information, please visit www.pyrogenesis.com

 

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

 

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTC Markets Group Inc. accepts responsibility for the adequacy or accuracy of this press release.

 

For further information: Rodayna Kafal, VP, Investor Relations and Communications, Phone: (514) 937-0002, E-mail: [email protected] or [email protected]

Tetra Bio-Pharma Inc. $TBP.ca Rx Princeps(TM) Now Available for Patients through Licensed Producer Partner Aphria $APH.ca $AERO $CBDS $CGRW $GBLX

Posted by AGORACOM-JC at 8:23 AM on Thursday, November 16th, 2017

Logo tetrabiopharma rgb web

  • Announced that Rx Princeps™, unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc.

OTTAWA, ONTARIO–(Nov. 16, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that Rx Princeps™, unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc. (“Aphria”) under Access to Cannabis for Medical Purposes Regulations (ACMPR).

Based on the most recent ACMPR market data from the Government of Canada, it is estimated that the sales of dried medical cannabis in Canada from April 2017 to March 2018 will be over $188M; Tetra is now entering this lucrative market and plans on progressively grabbing a significant share of it over the next two years. Mr Fortier, CEO of Tetra, stated last week “We are expecting to generate around $1.5 million in sales, in fiscal 2018 in our initial launch. Through our promotion and education efforts in Quebec, New Brunswick and part of Ontario, we estimate that over eight thousand patients will start using Rx Princeps™ under prescription from their doctors over in the next twelve months.”

Rx Princeps™ is a new option for doctors who want to prescribe medical cannabis. Prescribing Rx Princeps™ with the Rx Princeps™ inhalation device enables their patients to optimize the benefits of medical cannabis through the intake of a fixed dose of product, thereby ensuring consistency of treatment with a standardized high-quality product.

Aphria grows and produces medical cannabis under a strict quality management program. Tetra chose Aphria as its partner because their production processes were adopted from the highly restricted and regulated pharmaceutical industry, and go above and beyond cannabis industry regulations mandated by Health Canada. As a result, Aphria’s products are in line with the strict quality standards Tetra is establishing for the medical community and its patients.

200,000 patients are already registered under the ACMPR program and around 1.5 million adults in Canada suffer from chronic pain and are considered non-responders to opioids; medical cannabis could be a new therapeutic choice for those patients but physicians need bioavailability and safety data to prescribe medical cannabis with confidence. According to Health Canada, less than 3,000 physicians actually prescribe cannabis to their patients. Tetra is committed to provide them rigorous safety and bioavailability data. Tetra has begun educating pain clinics and the medical profession across Canada on Rx Princeps™, including its advantages for patients.

In Quebec, Tetra is working closely with Sante Cannabis in order to educate patients and support them in their medical journey with cannabis. Sante Cannabis is the first cannabinoid clinic and medical marijuana resource centre in Quebec.

About Rx Princeps™:

Rx Princeps™ is a unique blend of 3 strains of medical cannabis. Its production has been standardized in order to ensure a lot-to-lot consistent composition in its active ingredients (THC and CBD). Rx Princeps™ is composed of the same medical cannabis blend used to produce PPP001, which has demonstrated its safety in the Phase 1 clinical trial of PPP001. Patients who want to purchase Rx Princeps™ in Canada need a prescription from their physicians and to register with Licensed Producer Aphria.

About Tetra Bio-Pharma:

Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products.

More information at: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; the success of the Rx Princeps product offering and inhalation device; guidance on expected sales volumes associated with the Rx Princeps product offering and inhalation device; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Dr. Anne-Sophie Courtois, DVM
Vice President, Marketing & Communications
(514) 360-8040 Ext. 210
[email protected]
www.tetrabiopharma.com

Namaste $N.ca Provides Corporate Update on #Cannmart and Namaste MD #MMJ #Marijuana

Posted by AGORACOM-JC at 8:19 AM on Thursday, November 16th, 2017

Nlogo

  • Provides an update on progress with its wholly owned subsidiary, Cannmart Inc.
  • Updated Access to Cannabis for Medical Purposes Regulations application has been submitted to Health Canada, the CannMart facility is now under construction
  • Company expects a six to eight-week time-frame for completion, pending any delays

VANCOUVER, British Columbia, Nov. 16, 2017 — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N)(FRANKFURT:M5BQ)(OTCMKTS:NXTTF) is pleased to provide an update on progress with its wholly owned subsidiary, Cannmart Inc. (“CannMart”). Management is excited to announce that the updated Access to Cannabis for Medical Purposes Regulations (“ACMPR”) application has been submitted to Health Canada, the CannMart facility is now under construction and the Company expects a six to eight-week time-frame for completion, pending any delays. Namaste’s design goals for the CannMart facility will facilitate the seamless distribution of a wide variety of medicinal cannabis products, which have been sourced both domestically and internationally. Namaste believes that once construction is complete, this state of the art facility will serve as the backbone in servicing Namaste’s impressive and growing database of Canadian medical cannabis consumers.

Further to Namaste’s press release dated November 14, 2017, the application for NamasteMD, the Company’s innovative telemedicine smart-phone app, has been submitted to both the Apple Store and Google for approval, and will available on both IOS and Android devices once approval is received. Additionally, Namaste is pleased to announce that it has engaged multiple doctors and nurse practitioners who will be trained to provide consultations on the NamasteMD app and issue medical documents to Namaste’s patients. NamasteMD has been designed to provide a simple process for patients to connect with a doctor or nurse practitioner through a virtual consultation from the comfort of their home or office. NamasteMD incorporates proprietary identity and age verification technology that will provide high confidence verification for all patients.  Patients who complete their consultation and receive a medical document through NamasteMD may then connect to CannMart’s online portal where they can purchase a wide range of medicinal cannabis products. By utilizing Namaste’s innovative technology of machine-learning algorithms and integrating CannMart on the NamasteMD platform, Namaste strongly believes that it will soon become Canada’s leading online retailer for medicinal cannabis.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments: “These are extremely exciting times for Namaste as we move forward and implement many new and innovative initiatives. We are very excited about the progress of both CannMart and NamasteMD and believe the next few months will be transformational for the Company. I would like to thank all shareholders for their continued support and in helping Namaste reach these important milestones.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors
“Sean Dollinger”
Chief Executive Officer
+1 (786) 389 9771
Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

www.namastetechnologies.com

www.namastevaporizers.com

www.namastevaporizers.co.uk

www.everyonedoesit.com

www.everyonedoesit.co.uk

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Are #Esports going to replace the beautiful game? $GMBL #ManUtd

Posted by AGORACOM-JC at 11:47 AM on Wednesday, November 15th, 2017

  • The best gamers have millions who follow their lives. Images of Faker, a 21-year-old bespectacled South Korean described as the Michael Jordan of League Of Legends (a multiplayer online battle arena)
  • They make millions through prizes, appearance fees or merchandise. They have fans and fan clubs who sing about and chant names of star players. There are transfers between teams.

I recently took the 256 bus from Urmston, via Stretford, to Old Trafford. I was on that bus frequently as a kid and it was packed with equally young, local Manchester United fans who paid to stand on the terraces which covered all four sides of Old Trafford. The bus trip was part of the day, a raucous experience, be it mixing with fellow fans, people from other schools or goading stray away fans from the safety of the upper deck.

As I got off the 256 outside the Bishop Blaize pub on my way to watch United beat Everton, the only other passengers disembarking were five stadium catering staff. There wasn’t a single United fan.

Old Trafford has been expanded, but it’s still full for every league game and going to games is not accessible like it was. The average age of the fan has increased steadily since the Taylor Report. You still see kids at games, but they’re not the unaccompanied gangs of yore, but shepherded by an adult into the family stand. The rest of the stadium is populated largely by the middle-aged onwards

United are hamstrung as they can’t turf fans out for being old, though the club do work hard to offer tickets for cup games where demand is lower. Having established that the average age of an MUTV viewer is 53, they’re also trying to attract younger fans to a new app.

It’s not just United. A friend who stood on the terraces at his beloved AFC Wimbledon last week was struck by the profile of those around him.

“They were all old men,” he stated. “The hardcore, the faithful. I’m a bit worried about our prospects at our new home if we don’t attract more young people.”

Wimbledon have been an incredible success, but they attract crowds of 4,000 in a division where Bradford average 20,000, Portsmouth 17,000, Charlton and Blackburn 11,000. Without a benefactor, Wimbledon are doing well to be where they are, even if there’s a lack of goals and great games. My friend suspected that younger people had more exciting pursuits to occupy their time.

There are alternatives. I grew up in a football city where if you were into football, you either played it or you went to support your team. Or you did both. If you didn’t go to games then you weren’t considered a proper football fan, and televised games were few and not a substitute for the real thing.

Now, most people who support Manchester United don’t go to games. There’s been a gigantic shift, with United’s global support watching every kick on screens of varying sizes. There’s no need to miss a game. While televised football was once considered a grievous threat to match-going attendances, now it barely matters.

PA Photos

Far more people are watching football, both in person and televised, than ever before. Compare the average attendances from 1986 to today’s. Manchester United’s was 46,321 (now 75,027), Manchester City’s 24,299 (52,268), Liverpool‘s 35,271 (53,191), Arsenal‘s 23,824 (59,290), Chelsea‘s 21,984 (41,501) and Tottenham‘s 20,859 (70,724).

English football is incredibly popular, stadiums continue to expand, thanks mainly to lucrative television deals. There are three fifth-tier teams with average crowds above 4,000 – it’s unheard of outside England. But are the kids attending? And, if not, what else are they doing?

I was recently asked to host an interview on eSports in Lisbon with Sam Mathews, the founder and chairman of something called Fnatic. A Melbourne-raised Shoreditch resident, Mathews’ Fnatic has been called the Manchester United of its genre with its Counter-Strike team former world champions. The team even has a coach.

I’d never heard of it, nor knew much of eSports or eGamers – a phrase Sam quickly corrected me as a no-no, suggesting that eAthletes was more appropriate.

Athletes? It was explained that while they might not be running around a field, they were showing skills in other ways, through co-ordination, daring moves against rivals, practice and dedication. They were bringing joy to millions, too.

I assumed that people who played a lot of computer games were pasty-faced geeks who struggled with real-life social interaction. I was in for a surprise, but the interview brief seemed ridiculous. “Can eSports franchises build a brand similar to that of Real Madrid and Manchester United?”

The interview was on a stage in front of 900 seats at the Lisbon Web Summit. All appeared taken. The crowd were asked if they’d heard of Manchester United. Almost all raised their hands. Then they were asked if they’d heard of Fnatic. A similar number raised their hands.

Sam explained how 60,000 had recently watched an eSports event at Beijing’s iconic Bird Nest stadium. I struggled to get my head around why anyone would travel to watch people play computer games, but I was the odd one out here.

The best gamers have millions who follow their lives. Images of Faker, a 21-year-old bespectacled South Korean described as the Michael Jordan of League Of Legends (a multiplayer online battle arena), sobbing after an unexpected defeat last year brought an outpouring of emotion and sympathy from millions.

They make millions through prizes, appearance fees or merchandise. They have fans and fan clubs who sing about and chant names of star players. There are transfers between teams.

This phenomenon has largely escaped the mainstream – eAthletes don’t make the news or the covers of magazines, which tend to go for real-world stories. But the mainstream is now sitting up and taking notice. Manchester City and Paris Saint-Germain are among two of the clubs now employing professional eAthletes. There’s an alternate Dutch Eredivisie for gamers.

Thirty million watched the 2016 League Of Legends World Championship, where the winners took $2.68 million in prize money. Little wonder mainstream television channels want a piece. The people behind LA’s bid for the 2024 Olympics considered proposing eSports for inclusion.

Interview over, it was time to hear other views when I spoke to eSport fans. They wanted to know what was the big deal about paying £40 to sit in the cold and see one goal in 90 minutes at a conventional football game?

I imagined being a 10-year-old being taken to watch Louis van Gaal’s Manchester United. I’d probably have been back on Space Invaders as quickly as possible.

Other eSport advocates talked of their communities, their friendships with people around the world; technology has allowed that, though the virtual and real seem to blur. Isn’t that the same in other areas of life, when people are registered on forums under pseudonyms? United, along with several other top clubs, are trialling virtual reality in training sessions.

The eSport fans were also curious to know what was so great about travelling hundreds of miles to watch a game that had been switched for the benefit of television? And when I talked of how unhealthy it must be to spend ten franchises’ hours a day in front of a screen, they pointed out that football fans were hardly renowned for being paragons of health.

Where there’s mass interest, money will follow. The biggest Korean firms already sponsor teams of professional eAthletes. The last two championships have been staged in Los Angeles. It’s accessible, fast improving, attractive, well marketed and a threat to conventional, professional sport games such as football, cricket, baseball, boxing or rugby – sports conceived in England and exported via the British Empire. Who’s to say there shouldn’t be new mass appeal sports?

Anyway, for me – admittedly in my forties and fitting the demographic perfectly – the buzz is from anticipating everything that goes with Newcastle at home on Saturday. Should I get the bus or the tram? And those paper fanzines need protecting if it rains.

Source: http://www.gq-magazine.co.uk/article/are-esports-going-to-replace-the-beautiful-game

INTERVIEW: Namaste $N.ca Discusses Acquisition of Brazil’s LARGEST #Vaporizer Retailer (AT NO COST) $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 7:59 AM on Wednesday, November 15th, 2017

Nlogo

AGORACOM Founder, George Tsiolis, sat down with Namaste CEO, Sean Dollinger, to produce the most powerful Namaste interview yet.  This is a must watch for anyone invested in the Cannabis / Medical Marijuana space.  The Topics include:

  1. The Company’s latest Brazil acquisition. Adding 10,000 customers, $1M Revenues AT NO COST … and projecting to generate $350,000 in Net Income BEFORE growing top line revenues.
  2. NamasteMD, the pending iPhone App (and Android) that seamlessly connects patients, their medical records, doctors and facial recognition technology to access Medical Marijuana.
  3. Becoming the Amazon of the Vapes & Cannabis Industries.
  4. Doubling Growth every year for the next several years.

There is no other way to say it. Namaste Technologies is the e-commerce powerhouse of this industry … and we know what the technology leader can do to non-tech industry encumbents. Think Amazon, Uber, Airbnb and more.

WATCH

Peeks Social Ltd. $PEEK.ca Signs Binding LOI with Personas to Acquire Peeks Social Technology

Posted by AGORACOM-JC at 5:21 PM on Tuesday, November 14th, 2017

Peeks large

  • Entered into a binding Letter of Intent with Personas.com Corporation  and Riavera Corporation for the acquisition of the technology assets of the Peeks Social livestreaming product
  • Launched in November 2016, along with certain other related technology assets

TORONTO, Nov. 14, 2017 — Peeks Social Ltd. (TSXV:PEEK) (OTCQB:PKSLF) (“Peeks Social” or “the Company”) is pleased to announce that it has entered into a binding Letter of Intent (“LOI”) with Personas.com Corporation (“Personas”) and Riavera Corporation (“Riavera”) for the acquisition of the technology assets of the Peeks Social livestreaming product launched in November 2016, along with certain other related technology assets (the “Technology”).

By way of background, the Company initially entered into a technology licensing agreement with Personas on August 14, 2015, pursuant to which Personas agreed to pay the Company a licensing fee equal to 10% of the gross revenue earned by Personas through the use of the Company’s platforms (the “Licensing Agreement”).  The Licensing Agreement was subsequently amended in October 2016 to increase the licensing fee payable to the Company from 10% to 30%. The Licensing Agreement formed the foundation for the product initiative “Peeks Social”, a commerce enabled livestreaming service currently available for download in the iOS and Android app stores. Upon a successful completion of the proposed transaction, the Company would receive 100% of the gross revenue of the Peeks Social livestreaming product.

The LOI contemplates the Company acquiring the Technology in exchange for the issuance of 175,150,520 common shares at a negotiated price of $0.7308 per common share, an acquisition cost of $128,000,000 (the “Transaction”). The closing price of the Company’s common shares on the TSX Venture Exchange on November 10, 2017, was $0.37. It is anticipated that following the Transaction there will be 234,126,791 issued and outstanding common shares of the Company.

There are currently 61,976,271 issued and outstanding common shares of the Company. The Company has a fully diluted common share count of 79,454,933. Following the Transaction, the existing shareholders of Peeks Social Ltd. are anticipated to own 26.5% of the Company on an undiluted basis, and 31.6% of the Company on a fully diluted basis. Personas is an existing shareholder of the Company and currently owns 3,000,000 common shares which are anticipated to be returned to treasury for no additional consideration as part of the Transaction.

Description of the Transaction

It is anticipated that Personas and the Company will effect the Transaction by entering into a definitive agreement to complete an amalgamation, plan of arrangement, reorganization, or similar transaction, and subsequently carry on business as “Peeks Social Ltd.” The principal components of the Transaction are anticipated to be as follows:

  1. Immediately prior to the Transaction, the Technology will reside in Personas;
  2. Immediately prior to the Transaction, the Company will be continued as a corporation under the Business Corporations Act of Ontario (from Alberta);
  3. The parties will have received a final independent valuation report that confirms that the value of the Technology is at least $130,000,000; and
  4. Personas will use its good faith efforts to require its shareholders not to sell, transfer, or encumber their respective shares of the Company for a period of four months following the completion of the Transaction.

Relationship between the Company, Personas, and Riavera

Personas is a private company controlled by Mr. Mark Itwaru, Chairman & CEO of the Company. Riavera is an existing “Control Person” of the Company within the meaning of the rules and policies of the TSX Venture Exchange, and is a significant shareholder of the Company and a related party to Personas. Collectively, these parties own an aggregate of 18,602,388 common shares of the Company, representing 30.0% of the issued and outstanding shares of the Company (non-diluted). Accordingly, the proposed Transaction between the Company and Personas would be considered a “related-party transaction” pursuant to the rules of the TSX Venture Exchange and Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions, and the Transaction is subject to minority shareholder approval and valuation requirements, as well as TSX Venture Exchange approval.

The Company established an independent special committee of its Board of Directors in July 2017 to explore and negotiate the acquisition of the Technology. Mr. Itwaru recused himself from the negotiations as a result of his interest in Personas. The independent special committee has recommended the Company proceed with the Transaction, subject to the terms and conditions of the LOI.

Definitive Agreements, Conditions, and Proposed Closing

The LOI currently contemplates the parties entering into a definitive agreement (the “Definitive Agreement”) prior to November 30, 2017, and completing the Transaction by December 31, 2017, unless otherwise agreed by the parties.  The LOI may be terminated by either party in certain circumstances, including if the Definitive Agreement is not executed prior to November 30, 2017, or if either party is not satisfied with its due diligence review. The Transaction is subject to requisite regulatory approvals, including the approval of the TSX Venture Exchange, shareholder approval and standard closing conditions, including the approval of the Definitive Agreement by the boards of the respective companies and completion of due diligence investigations to the satisfaction of each of the parties. The legal structure for the Transaction will be confirmed after the parties have considered all applicable tax, securities law, and accounting efficiencies.

The TSX Venture Exchange has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

For further information, please contact:

Peeks Social Ltd.
Mark Itwaru
Chairman & Chief Executive Officer
416-815-7000 x303
[email protected]

David Vinokurov
Director Investor Relations
416-716-9281
[email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this Release.

Forward-Looking Statements

This news release contains forward-looking statements relating to the timing and completion of the proposed Transaction and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the proposed Transaction and the future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. As a result, the Company cannot guarantee that the proposed Transaction will be completed and that any forward-looking statement will materialize and the reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and while the Company may update or revise publicly any of the included forward-looking statements in the future, it undertakes no obligation to publicly update or revise any forward-looking information except as required by law.

ThreeD Capital Inc. $IDK.ca Announces Completion of Private Placement to Raise $1,605,000 And Exercise of Warrants $PNP.ca $ZC.ca

Posted by AGORACOM-JC at 4:08 PM on Tuesday, November 14th, 2017

Threed capital

  • Completed a non-brokered private placement
  • Pursuant to which it has issued 8,025,000 units at a price of $0.20 per Unit to raise aggregate gross proceeds of $1,605,000

TORONTO, Nov. 14, 2017 — ThreeD Capital Inc. (the “Company”) (CSE:IDK) is pleased to announce that it has completed a non-brokered private placement (the “Offering”), pursuant to which it has issued 8,025,000 units (“Units) at a price of $0.20 per Unit to raise aggregate gross proceeds of $1,605,000.  Each Unit consists of one common share of the Company and one common share purchase warrant (a “Warrant”).  Each Warrant entitles the holder thereof to acquire one additional common share of the Company at an exercise price of $0.25 until November 14, 2020.

All securities issued and issuable in connection with the Offering are subject to a statutory hold period expiring on March 15, 2018.  Proceeds of the Offering will be used for investment purposes and general working capital.

The Company is also pleased to announce that a total of 6,650,000 common shares have been issued  as a result of the exercise of common share purchase warrants since October 25, 2017 at a weighted average price of $0.11 per common share. This results in $717,500 of aggregate proceeds to the Company.  The exercise of these warrants represent a strong vote of confidence by our shareholders and proceeds from the exercised warrants will be used for investment purposes.

About ThreeD Capital Inc.

ThreeD Capital Inc. is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources, Artificial Intelligence and Blockchain sectors.

ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services, mentoring and access to the Company’s network in order to earn increases to the Company’s equity stake.

For further information:
Gerry Feldman, CPA, CA
Chief Financial Officer and Corporate Secretary
[email protected]
Phone: 416-606-7655

St-Georges’ $SX.ca Subsidiary Kings of the North Corp Signs Letter Of Intent To Option Canadian Orebodies’ Hemlo North Limb Gold Project

Posted by AGORACOM-JC at 3:56 PM on Tuesday, November 14th, 2017

Sx large

  • Pleased to report on the progress of newly formed subsidiary, Kings of the North Corp. and its plans to option or “farm-in” the Hemlo North Limb Project
  • Company has entered into a Letter of Intent (“LOI”) with Canadian Orebodies (TSX-V: CORE)

TheNewswire / November 14, 2017 / St-Georges Platinum & Base Metals ltd. (CSE: SX) (OTC: SXOOF) (FSE: 85G1) is pleased to report on the progress of newly formed subsidiary, Kings of the North Corp. and its plans to option or “farm-in” the Hemlo North Limb Project.

The company has entered into a Letter of Intent (“LOI”) with Canadian Orebodies (TSX-V: CORE) in order to option or “farm-in” CORE’s Hemlo North Limb Property which is located approximately 17 km northeast of the Hemlo gold mine in the Ontario’s Marathon district. It covers approximately 7,008 hectares. A highway bisects the project providing good access to much of the property. A NI 43-101 Technical Report was completed in December 2016.

KOTN interest in the project is driven by the similarity of formations within the project boundaries and at the nearby Hemlo Mine. These porphyry bodies contain gold within and adjacent to the property boundaries of the Hemlo North Limb Property. In addition, multiple gold and precious metal targets occur within banded iron formation and volcanic hosted massive sulfides. The company believes the multitude of gold and base metal targets generated by past work coupled with geophysical anomalies and historic drilling have de-risked the next phase of exploration. (See Figure 1. Below)


Click Image To View Full Size

Figure 1. Hemlo North Limb Property, Map of Mineral Occurrences

Kings of the North Corp. intends to complete a reconnaissance program in the spring which will follow up on all VTEM anomalies and proposed drill targets before prioritizing its drilling program in summer, 2018.

Kings of the North President, Mark Billings commented, “Kings of the North Corp. is very pleased to have entered into this agreement with Canadian Orebodies. We are excited about working with Canadian Orebodies to explore and develop the Hemlo North Limb Gold Property. This transaction represents a major step of our acquisition and development strategy for KOTN.”

Terms of the Transaction

The LOI describes the terms and the conditions that should lead to a formal agreement. The parties agree that the Definitive Agreement will not be entered into until KOTN can demonstrate that it has raised at least $3,000,000 in equity financing.

In order to acquire an initial 50% interest in the Hemlo North Limb Property, KOTN agrees to:

-Pay to CORE a $50,000 cash deposit, on or before December 31, 2017

-Upon execution of the Definitive Agreement, issue to CORE a $350,000 principal amount secured convertible note bearing interest at a rate of 15% per annum, calculated monthly but payable on maturity. The principal and accrued interest under the First Convertible Note will be convertible at the option of the holder at any time into common shares of KOTN at a conversion price equal to the lesser of the volume-weighted average price (“VWAP”) of KOTN’s common shares for the 20 trading days prior to conversion or, if KOTN is not a public company at the time of conversion, the price or deemed price per KOTN common shares in the most recent transaction in which KOTN issued common shares or securities convertible into KOTN common shares.

-Incur or cause to be incurred exploration expenditures of $2,000,000 on the Properties before December 31, 2018

In order to acquire an additional 25% interest in the Hemlo North Limb Property (for a total of 75%), KOTN agrees to:

 

-Issue to CORE a $650,000 principal amount secured convertible note bearing interest at a rate of 15% per annum, calculated monthly but payable on maturity. The principal and accrued interest under the Second Convertible Note will be: (a) convertible at the option of the holder at any time prior to KOTN’s becoming a Public Company into common shares of KOTN at a conversion price equal to the price or deemed price per KOTN common share in the most recent transaction in which KOTN issued common shares or securities convertible into KOTN common shares; and (b) if not previously converted, shall be automatically converted at the deemed stock exchange listing price of KOTN’s common shares upon KOTN’s becoming a Public Company.

-Incur or cause to be incurred an additional $2,000,000 in exploration expenditures on the Properties and provide a NI 43-101 technical report before December 31, 2019.

In order to acquire an additional 10% interest in the Hemlo North Limb Property (for a total of 85%), KOTN agrees to deliver a positive pre-feasibility study (with going forward recommendations) on the Project before December 31, 2021.

Canadian Orebodies Buyback Option

Canadian Orebodies has the option to buy back up to a 25% interest in the Properties by making the following payments to the Purchaser:

-$1,000,000, and

-300% x (the qualified expenditures incurred by the Purchaser, as well as any amounts incurred in relation to the production of a technical report and/or a pre-feasibility study) x (percent interest to be bought back by the Vendor)

For example, assume the Purchaser obtains an 85% interest in the Properties after having spent $5,000,000 in total, and the Vendor wishes to buy back a 25% interest in the Properties. The Vendor would have to pay to the purchaser:

-$1,000,000 +

-300% x $5,000,000 x 25% = $3,750,000

-TOTAL = $4,750,000.

Thus, after having paid to the Purchaser the amount of $4,750,000, the Vendor would then have a 40% interest in the Properties and the Purchaser would be reduced to 60%.

Kings of the North and Canadian Orebodies shall provide additional information in regards to the contemplated transaction and its progress in the coming weeks.

Herb Duerr, CP.Geo, St-Georges’ Director is a qualified person under NI 43-101 and has reviewed and approved the technical content of this release.

ON BEHALF OF THE BOARD OF DIRECTORS

 

“Mark Billings”

 

MARK BILLINGS, PRESIDENT & CEO OF KINGS OF THE NORTH CORP. AND CHAIRMAN OF THE BOARD OF ST-GEORGES PLATINUM LTD.

 

About St-Georges

 

St-Georges is developing new technologies with the goal of solving some of the well-known environmental problems in the mining industry.

 

The Company controls directly or indirectly, through first refusal right, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi area. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1. For additional information, please visit our website at www.stgeorgesplatinum.com

 

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

 

Copyright (c) 2017 TheNewswire – All rights reserved.

HPQ Silicon $HPQ.ca Announces Equity Financing to Advance PUREVAP(TM) Testing and Commencement of Pilot Plant Equipment Build Out $FSLR $SPWR $CSIQ $NEP

Posted by AGORACOM-JC at 3:53 PM on Tuesday, November 14th, 2017

Hpq large

  • Proceeding with a non-brokered equity financing to support the advancement of its ongoing PUREVAP™ Quartz Reduction project
  • Current round of funds are targeted at advancing Gen2 testing and commencement of the Pilot Plant Equipment build out

MONTREAL, QUEBEC–(Nov. 14, 2017) – HPQ Silicon Resources Inc (“HPQ”) (TSX VENTURE:HPQ)(FRANKFURT:UGE)(OTC PINK:URAGF) is pleased to inform shareholders that it is proceeding with a non-brokered equity financing to support the advancement of its ongoing PUREVAP™ Quartz Reduction project. The current round of funds are targeted at advancing Gen2 testing and commencement of the Pilot Plant Equipment build out.

Bernard Tourillon, Chairman and CEO of HPQ Silicon stated: “This round of funding will provide HPQ-Silicon with the resources and flexibility to continue the advancement of the Gen2 testing and Pilot Plant Equipment project with PyroGenesis. After this round, the remaining capital expenditure to complete the entire project, including running the Pilot Plant Equipment, is estimated to be $3.8 million. Regarding the financing of the $3.8 million, HPQ management is in discussion with institutions in order to complete the financing package during 2018.”

Terms of the proposed Private Placement

HPQ-Silicon is proceeding with a non-brokered private placement of up to 11,400,000 units (“Unit”) at $0.10 per Unit for gross proceeds of up to $1,140,000. Insider participation in this placement could account for up to 5% of the total amount subscribed.

Net proceeds of the placement will be used for on-going business development costs related to the development of HPQ PUREVAP™ Quartz Reduction Reactor project and 200 TPY Pilot Plant Equipment, general corporate expenses, placement fees and legal expenses. If demand warrants it, the placement may be increased by up to another 5,000,000 units.

Each Unit is comprised of one (1) common share and one (1) common share purchase warrant (“Warrant”) of the Company. Each Warrant will entitle the holder thereof to purchase one common share of the capital stock of the Company at an exercise price of $ 0.15 during a period of 36 months from the date of closing of the placement. Each share issued pursuant to the placement will have a mandatory four (4) month and one (1) day holding period from the date of closing of the placement. The placement is subject to standard regulatory approvals.

The Corporation will pay Finder’s Fees, subject to the TSX-V policies, to introducing agents that participate in the private placement.

La version française du communiqué de presse sera disponible sur http://www.hpqsilicon.com

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

About HPQ Silicon

HPQ Silicon Resources Inc is a TSX-V listed resource company planning to become a vertically integrated and diversified Metallurgical Grade and Solar Grade Silicon Metal producer.

Our business model is focused on developing a disruptive one step High Purity and Solar Grade Silicon Metal manufacturing process (patent pending). HPQ plans to generate high yield returns and significant free cash flow within a relatively short time line. The process will have a greatly decreased carbon footprint, energy footprint, and will eliminate the use of the toxic chemical reagents and by products now in use by the current solar silicon production technologies, which fundamentally date from designs made in the mid 1900’s.

Disclaimers:

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or the securities laws of any state of the United States and may not be offered or sold within the United States or to, or for the account or the benefit of, U.S. persons (as defined in Regulation S un der the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the securities regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Shares outstanding: 173,678,173

HPQ Silicon Resources Inc.
Bernard J. Tourillon
Chairman and CEO
(514) 907-1011

HPQ Silicon Resources Inc.
Patrick Levasseur
President and COO
(514) 262-9239
www.HPQSilicon.com